Aspen Aerogels (NYSE:ASPN – Get Free Report) had its price target lowered by equities researchers at Canaccord Genuity Group from $28.00 to $20.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the construction company’s stock. Canaccord Genuity Group’s price target suggests a potential upside of 57.17% from the company’s current price.
Several other research firms have also commented on ASPN. Roth Mkm decreased their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Barclays lowered their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research report on Tuesday, November 12th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Finally, Piper Sandler lowered their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.11.
Get Our Latest Stock Report on ASPN
Aspen Aerogels Stock Performance
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of ASPN. Point72 Hong Kong Ltd acquired a new position in Aspen Aerogels in the 2nd quarter worth about $84,000. Quent Capital LLC bought a new stake in shares of Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd acquired a new position in shares of Aspen Aerogels in the second quarter valued at approximately $121,000. nVerses Capital LLC raised its holdings in Aspen Aerogels by 45.0% in the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new stake in Aspen Aerogels during the 2nd quarter worth approximately $145,000. 97.64% of the stock is currently owned by institutional investors.
About Aspen Aerogels
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More
- Five stocks we like better than Aspen Aerogels
- What Investors Need to Know to Beat the Market
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to Choose Top Rated Stocks
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Quiet Period Expirations Explained
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.